Screener
Charles River Laboratories CRL RMS — Intangible asset impairment
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsFinitelived.
The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 9:21 AM EST
- Fiscal year
- FY2025
- Accession
- 0001100682-26-000022
| Line item | Fiscal Year / December 27, 2025 | Fiscal Year / December 28, 2024 | Fiscal Year / December 30, 2023 |
|---|---|---|---|
| Cost of revenue (excluding amortization of intangible assets) | 576,250 | 580,491 | 509,970 |
| Selling, general and administrative | 101,529 | 110,982 | 105,965 |
| Amortization of intangible assets | 21,736 | 23,493 | 21,742 |
| Intangible asset impairment | 102,000 | — | — |
| Operating income | $44,567 | $114,411 | $154,666 |
| DSA | |||
| Revenue | $2,402,891 | $2,451,280 | $2,615,623 |
| Cost of revenue (excluding amortization of intangible assets) | 1,686,017 | 1,697,166 | 1,675,472 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Charles River Laboratories's RMS — intangible asset impairment?
- Charles River Laboratories (CRL) reported RMS — intangible asset impairment of $52.75M in Q4 2025.
- What does RMS — intangible asset impairment mean?
- This metric reflects the non-cash charge recognized when the carrying value of intangible assets within the Research Models and Services segment exceeds their fair value. It indicates a reduction in the expected future economic benefits of acquired assets like patents, customer relationships, or technology.
Ask your AI about Charles River Laboratories's rms — intangible asset impairment.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude